| Sector |
Trading
|
Compare with Sector peers |
| Industry |
Trading
|
Compare with Industry peers |
| Website | http://www.evoqremedies.com | |
| Market Cap | 19.48 Cr. | |
| Enterprise Value(EV) | 19.45 Cr. | 2021-03 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 0.52 | Trailing Twelve Months Ending 2021-03 |
| Price-Earning Ratio (PE) | 27.28 | Trailing Twelve Months Ending 2021-03 |
| Industry PE | 119.83 | Trailing Twelve Months Ending 2021-03 |
| Book Value / Share | 16.74 | Trailing Twelve Months Ending 2021-03 |
| Price to Book Value | 0.86 | Calculated using Price: 14.32 |
| Dividend Yield | 0.00 | Period Ending 2021-03 |
| No. of Shares Subscribed | 1.36 Cr. | 13,600,000 Shares |
| FaceValue | 10 | |
| Company Profile | ||
|
EVOQ Remedies is one of the recognized trading house of Pharmaceuticals Raw Materials, Excipients, Bulk Drugs at affordable price catering to the customers located in Ahmedabad. It procures the pharmaceuticals Raw Materials products and chemicals from the suppliers which are having WHO-GMP approved production facilities in India and by focusing on its first-class distribution expertise. In the area of Pharmaceuticals Raw Materials, Excipients, Bulk Drugs etc., the company is specializes in offering quality products and affordable trading in Gujarat. The company has a team of focused industry experts, who have in-depth knowledge of the industry and have with them expertise in offering best solutions for meeting their specific needs. It procure all the products from certified & reliable Manufacturers & Importers, who follow procedures as per the stringent national and international quality and safety standards. In order to achieve the task, it keep its regular visit to ensure quality and reliability of the products. Keeping its basic objective in mind, it strive hard to exceed all the expectations of its clients by supplying best quality products at the most reasonable prices. EVOQ is having its registered office, corporate office and storage location facilities located in Ahmedabad. In the healthcare segment, EVOQ being into trading business offers a wide basket of products. EVOQ majorly does trading in following segments of pharmaceuticals raw materials:
Business area of the company The company specializes in offering quality Pharmaceuticals Raw Material products, Excipients, and Bulk Drugs at an affordable prices. Major events:
|
||
Company Profile
EVOQ Remedies is one of the recognized trading house of Pharmaceuticals Raw Materials, Excipients, Bulk Drugs at affordable price catering to the customers located in Ahmedabad. It procures the pharmaceuticals Raw Materials products and chemicals from the suppliers which are having WHO-GMP approved production facilities in India and by focusing on its first-class distribution expertise.
In the area of Pharmaceuticals Raw Materials, Excipients, Bulk Drugs etc., the company is specializes in offering quality products and affordable trading in Gujarat. The company has a team of focused industry experts, who have in-depth knowledge of the industry and have with them expertise in offering best solutions for meeting their specific needs. It procure all the products from certified & reliable Manufacturers & Importers, who follow procedures as per the stringent national and international quality and safety standards. In order to achieve the task, it keep its regular visit to ensure quality and reliability of the products. Keeping its basic objective in mind, it strive hard to exceed all the expectations of its clients by supplying best quality products at the most reasonable prices. EVOQ is having its registered office, corporate office and storage location facilities located in Ahmedabad. In the healthcare segment, EVOQ being into trading business offers a wide basket of products.
EVOQ majorly does trading in following segments of pharmaceuticals raw materials:
Business area of the company
The company specializes in offering quality Pharmaceuticals Raw Material products, Excipients, and Bulk Drugs at an affordable prices.
Major events:
| 1 Day |
|
-6.04% |
| 1 Week |
|
-8.79% |
| 1 Month |
|
-13.47% |
| 3 Month |
|
|
| 6 Month |
|
|
| 1 Year |
|
|
| 2 Year |
|
|
| 5 Year |
|
|
| 10 Year |
|
| 3 years | 2019-03 | 2020-03 | 2021-03 | |
| Return on Equity (%) | 49.78 | 1.34 | 188.09 | |
| Return on Capital Employed (%) | 68.94 | 2.69 | 247.43 | |
| Return on Assets (%) | 0.52 | 0.01 | 10.42 |
| Particulars | 3 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. |
| Shh. Funds | 0 | 0 | 1 | |
| Non Curr. Liab. | 0 | 0 | ||
| Curr. Liab. | 2 | 6 | 7 | |
| Minority Int. | ||||
| Equity & Liab. | 2 | 6 | 8 | |
| Non Curr. Assets | ||||
| Curr. Assets | 2 | 6 | 8 | |
| Misc. Exp. not W/O | ||||
| Total Assets | 2 | 6 | 8 |
| Particulars | 3 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. |
| Net Sales | 3 | 9 | 10 | |
| Other Income | ||||
| Total Income | 3 | 9 | 10 | |
| Total Expenditure | -3 | -9 | -9 | |
| PBIDT | 0 | 1 | ||
| Interest | ||||
| Depreciation | ||||
| Taxation | 0 | |||
| Exceptional Items | ||||
| PAT | 0 | 1 | ||
| Adjusted EPS |
| Particulars | 3 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. |
| Cash Fr. Operatn. | 0 | 0 | 0 | |
| Cash Fr. Inv. | ||||
| Cash Fr. Finan. | ||||
| Net Change | 0 | 0 | 0 | |
| Cash & Cash Eqvt | 0 | 0 |
|
Mon, 23 May 2022
Board Meeting Intimation for The Audited Financial Results Of The Company For The Quarter And Year Ended On 31St March 2022 Along With Auditor'S Report. Evoq Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2022 inter alia to consider and approve the Audited Financial Results of the Company for the Quarter and Year ended on 31st March 2022 along with Auditors Report. |
|||||||||||||||||||||
|
Sat, 30 Apr 2022
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A Format of Initial Disclosure to be made by an entity identified as a Large Corporate.
We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No Name of the Company Secretary: TEJ BHARATKUMAR HANJ Designation: Company Secretary EmailId: cs@evoqremedies.com Name of the Chief Financial Officer: YOGESH RAJPUT Designation: Chief Financial Officer EmailId: cs@evoqremedies.com Date: 30/04/2022 Note: In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. |
|||||||||||||||||||||
|
Sat, 30 Apr 2022
Submission Of Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For The Financial Year Ended On 31St March 2022 With reference to the captioned subject kindly find attached herewith Certificate issued under Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 for the financial year ended on 31st March 2022. Kindly take the same on your record and oblige us.Thanking You |
| Tue, 24 May 2022 |
High Delivery Percentage
|
Close Crossing Last Month Close from Above
|
High Decrease 1 Month
|
Close Crossing 20 EMA From Above
|
| Mon, 23 May 2022 |
Opening at Low
|
Equities
M.F.
Sectors